APO-CLOBAZAM 10 MG
CLOBAZAM : 10 MG · DIN 02244638 · APOTEX INC
Health Canada status: MARKETED
What is APO-CLOBAZAM?
APO-CLOBAZAM 10 MG contains CLOBAZAM : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02244638, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 28-Nov-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is APO-CLOBAZAM used for?
Adjunctive therapy in patients with epilepsy who are not adequately stabilized with their current anticonvulsant therapy.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02244638 |
|---|---|
| Brand name | APO-CLOBAZAM |
| Generic / active ingredient | CLOBAZAM : 10 MG |
| Manufacturer | APOTEX INC |
| Strength | 10 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | TARGETED SUBSTANCES (CDSA IV) |
| ATC code | N05BA09 CLOBAZAM |
| AHFS class | 28:36.20.04 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 28-Nov-2001 |
How is it administered?
Adjunctive therapy in epilepsy. Start with low doses, especially in elderly/renal/hepatic patients. Avoid abrupt discontinuation; terminate by gradually tapering the dosage.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly detailed in the provided text (section header exists but content is missing from snippet).
How is it supplied?
Not explicitly detailed in the provided text (mentions "Dosage Forms, Composition and Packaging" section but specific bottle sizes are not listed in the snippet).
Contraindications
Hypersensitivity; myasthenia gravis; narrow angle glaucoma; history of drug/alcohol dependence; severe respiratory insufficiency; sleep apnoea; severe liver impairment; 1st trimester of pregnancy.
Warnings and precautions
Risk of addiction, abuse, misuse; life-threatening withdrawal; risks from concomitant use with opioids; serious skin reactions (SJS, TEN, DRESS); suicidal ideation; respiratory depression.
What can be used instead?
Other Canadian products sharing ATC code N05BA09 CLOBAZAM. 2 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| TEVA-CLOBAZAM | 10 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02238334 |
| CLOBAZAM-10 | 10 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02248454 |
| DOM-CLOBAZAM | 10 MG | TABLET | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02247230 |
| FRISIUM TAB 10MG | 10 MG | TABLET | HOECHST CANADA INC. | CANCELLED POST MARKET | DIN 00846392 |
| FRISIUM TABLET 10MG | 10 MG | TABLET | LUNDBECK PHARMACEUTICALS LLC | CANCELLED POST MARKET | DIN 02221799 |
| FRISIUM TABLETS 10MG | 10 MG | TABLET | HOECHST ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 01989634 |
| NTP-CLOBAZAM | 10 MG | TABLET | TEVA CANADA LIMITED | CANCELLED PRE MARKET | DIN 02347598 |
| PMS-CLOBAZAM | 10 MG | TABLET | PHARMASCIENCE INC | DORMANT | DIN 02244474 |
| RATIO-CLOBAZAM | 10 MG | TABLET | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | CANCELLED POST MARKET | DIN 02238797 |
Who else supplies CLOBAZAM worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CLOBAZAM appears in 37 registered pack listings across 12 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.